Taipei Exchange - Delayed Quote TWD

Bioptik Technology Incorporation (4161.TWO)

Compare
33.30 -0.60 (-1.77%)
At close: December 13 at 1:30:32 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Mr. Jin-Chang Yang GM & Chairman of the Board -- -- --
Kun Lie Wu Executive Officer -- -- --
Yao Ren Tu Executive Officer -- -- --

Bioptik Technology Incorporation

No. 188, Jhonghua South Road
Miaoli County
Zhunan, 35057
Taiwan
886 3 762 6699 https://www.bioptik.com.tw
Sector: 
Healthcare
Industry: 
Medical Devices

Description

Bioptik Technology Incorporation engages in the production and sale of medical devices and reagents worldwide. It offers EasyMate blood glucose monitoring systems; blood glucose/cholesterol/uric acid monitoring systems and its strips; and hyaluronic acid skin care products. The company also provides skin care products and dietary supplements, as well as biodiesel products. Bioptik Technology Incorporation was founded in 1999 and is based in Zhunan, Taiwan.

Corporate Governance

Bioptik Technology Incorporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

July 16, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers